Erratum: Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris (Appl Microbiol Biotechnol, (2012) 95, 3, (671-682), 10.1007/s00253-012-4067-3);Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris

Applied Microbiology and Biotechnology

Volumn 95, Issue 3, 2012, Pages 671-682

  Choi, Byung Kwon ^a   Warburton, Shannon ^a   Lin, Heping ^a   Patel, Rohan ^a   Boldogh, Istvan ^b   Meehl, Meehl ^a   d'Anjou, Marc ^a   Pon, Liza ^b   Stadheim, Terrance A ^a   Sethuraman, Natarajan ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Department of Medicine   (United States)

Author keywords

L. major STT3D; N glycan site occupancy; Oligosaccharyltransferase; Pichia pastoris

Indexed keywords

GLYCOPROTEINS; GLYCOSYLATION; MAMMALS; MONOCLONAL ANTIBODIES; RECOMBINANT PROTEINS; YEAST;

HUMAN GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR; L. MAJOR STT3D; OLIGOSACCHARYLTRANSFERASE; PHARMACOKINETICS AND PHARMACODYNAMICS; PICHIA PASTORIS; POST-TRANSLATIONAL MODIFICATIONS; RECOMBINANT GLYCOPROTEINS; SITE OCCUPANCY;

POLYSACCHARIDES;

ALCOHOL OXIDASE; GLYCAN; GLYCOPROTEIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANTIBODY; ENZYME ACTIVITY; GENE EXPRESSION; GENOMICS; HOMOLOGY; PROTEIN; RECOMBINATION; SUBSTRATE; YEAST;

ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; GLYCOPROTEIN SYNTHESIS; LEISHMANIA MAJOR; MAMMAL CELL; NONHUMAN; PICHIA PASTORIS;

LEISHMANIA MAJOR; MAMMALIA; PICHIA PASTORIS;

EID: 84864581699     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-012-4160-7     Document Type: Erratum

References (40)

1. Barnard GC, Kull AR, Sharkey NS, Shaikh SS, Rittenhour AM, Burnina I, Jiang Y, Li F, Lynaugh H, Mitchell T, Nett JH, Nylen A, Potgieter TI, Prinz B, Rios SE, Zha D, Sethuraman N, Stadheim TA, Bobrowicz P (2010) High-throughput screening and selection of yeast cell lines expressing monoclonal antibodies. J Ind Microbiol Biotechnol 37:961-971
2. Ben-Dor S, Esterman N, Rubin E, Sharon N (2004) Biases and complex patterns in the residues flanking protein N-glycosylation sites. Glycobiology 14:95-101
3. Betenbaugh MJ, Viswanathan K, Krag SS, Jones JG (2006) Improving protein N-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other N-glycosylationincreasing methods, and engineered hosts expressing products with increased N-glycosylation. International Published Application No. WO 2006107990
4. Cereghino LJ, Cregg JM (2000) Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 24:45-66
5. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD (2003) Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 31:3497-3500
6. Choi BK, Jiménez-Flores R (1996) The study of putative glycosylation sites in bovine ß-casein introduced by PCR-based site-directed mutagenesis. J Agric Food Chem 44:358-364
7. Choi BK, Bobrowicz P, Davidson RC, Hamilton SR, Kung DH, Li H, Miele RG, Nett JH, Wildt S, Gerngross TU (2003) Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc Natl Acad Sci USA 100:5022-5027
8. Choi BK, Actor JK, Rios S, d'Anjou M, Stadheim TA, Warburton S, Giaccone E, Cukan M, Li H, Kull A, Sharkey N, Gollnick P, Kocieba M, Artym J, Zimecki M, Kruzel ML, Wildt S (2008) Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response. Glycoconj J 25:581-593
9. Gawlitzek M, Estacio M, Fürch T, Kiss R (2009) Identification of cell culture conditions to control N-glycosylation site-occupancy of recombinant glycoproteins expressed in CHO cells. Biotechnol Bioeng 103:1164-1175
10. Goetze AM, Liu YD, Zhang Z, Shah B, Lee E, Bondarenko PV, Flynn GC (2011) High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. Glycobiology 21:949-959
11. Hamilton SR, Gerngross TU (2007) Glycosylation engineering in yeast: the advent of fully humanized yeast. Curr Opin Biotechnol 18:387-392
12. Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H, Mitchell T, Nett JH, Rausch S, Stadheim TA, Wischnewski H, Wildt S, Gerngross TU (2003) Production of complex human glycoproteins in yeast. Science 301:1244-1246
13. Hamilton SR, Davidson RC, Sethuraman N, Nett JH, Jiang Y, Rios S, Bobrowicz P, Stadheim TA, Li H, Choi BK, Hopkins D, Wischnewski H, Roser J, Mitchell T, Strawbridge RR, Hoopes J, Wildt S, Gerngross TU (2006) Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 313:1441-1443
14. Hese K, Otto C, Routier FH, Lehle L (2009) LmSTT3 parologs complemented Sc OST subunits. Glycobiology 19:160-171
15. Horwitz AH, Chang P, Better M, Hellstrom KE, Robinson RR (1988) Secretion of functional antibody and Fab fragment from yeast cells. Proc Natl Acad Sci USA 85:8678-8682
16. Igura M, Maita N, Kamishikiryo J, Yamada M, Obita T, Maenaka K, Kohda D (2008) Structure-guided identification of a new catalytic motif of oligosaccharyltransferase. EMBO J 27:234-243
17. Jacobs PP, Geysens S, Vervecken W, Contreras R, Callewaert N (2009) Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology. Nat Protoc 4:58-70
18. Jiang Y, Li F, Zha D, Potgieter TI, Mitchell T, Moore R, Cukan M, Houston-Cummings NR, Nylen A, Drummond JE, McKelvey TW, d'Anjou M, Stadheim TA, Sethuraman N, Li H (2011) Purification process development of a recombinant monoclonal antibody expressed in glycoengineered Pichia pastoris. Protein Expr Purif 76:7-14
19. Jones J, Krag SS, Betenbaugh MJ (2005) Controlling N-linked glycan site occupancy. Biochim Biophys Acta 1726:121-137
20. Kaplan HA, Welply JK, Lennarz WJ (1987) Oligosaccharyltransferase: the central enzyme in the pathway of glycoprotein assembly. Biochim Biophys Acta 906:161-173
21. Karaoglu D, Kelleher DJ, Gilmore R (1997) The highly conserved Stt3 protein is a subunit of the yeast oligosaccharyltransferase and forms a suncomplex with Ost3p and Ost4p. J Biol Chem 272:32513-32520
22. Kasturi L, Eshleman JR, Wunner WH, Shakin-Eshleman SH (1995) The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein. J Biol Chem 270:14756-14761
23. Krogh A, Larsson B, von Heijne G, Sonnhammer EL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305:567-580
24. Li H, Sethuraman N, Stadheim TA, Zha D, Prinz B, Ballew N, Bobrowicz P, Choi BK, Cook WJ, Cukan M, Houston-Cummings NR, Davidson R, Gong B, Hamilton SR, Hoopes JP, Jiang Y, Kim N, Mansfield R, Nett JH, Rios S, Strawbridge R, Wildt S, Gerngross TU (2006) Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat Biotechnol 24:210-215
25. Liu J, Mushegian A (2003) Three monophyletic superfamilies account for the majority of the known glycosyltransferases. Protein Sci 12:1418-1431
26. Maita N, Nyirenda J, Igura M, Kamishkiryo J, Kohda D (2010) Comparative structural biology of eubacterial and archaeal oligosaccharyltransferases. J Biol Chem 285:4941-4950
27. Mellquist JL, Kasturi L, Spitalnik SL, Shakin-Eshleman SH (1998) The amino acid following an Asn-X-Ser/Thr Sequon is an important determinant of N-linked core glycosylation efficiency. Biochemistry 37:6833-6837
28. Nasab FP, Schulz BL, Gamarro F, Parodi AJ, Aebi M (2008) All in one: leishmania major STT3 proteins substitute for the whole oligosaccharyltransferase complex in Saccharomyces cerevisiae. Mol Biol Cell 19:3758-3768
29. Nett JH, Gomathinayagam S, Hamilton SR, Gong B, Davidson RC, Du M, Hopkins D, Mitchell T, Mallem MR, Nylen A, Shaikh SS, Sharkey N, Barnard GC, Copeland V, Liu L, Evers R, Li Y, Gray PM, Lingham RB, Visco D, Forrest G, DeMartino J, Linden T, Potgieter TI, Wildt S, Stadheim TA, d'Anjou M, Li H, Sethuraman N (2012) Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris. J Biotechnol 157:198-206
30. Nilsson I, Kelleher DJ, Miao Y, Shao Y, Kreibich G, Gilmore R, von Heijne G, Johnson AE (2003) Photocross-linking of nascent chains to the STT3 subunit of the oligosaccharyltransferase complex. J Cell Biol 161:715-725
31. Potgieter TI, Cukan M, Drummond JE, Houston-Cummings NR, Jiang Y, Li F, Lynaugh H, Mallem M, McKelvey TW, Mitchell T, Nylen A, Rittenhour A, Stadheim TA, Zha D, d'Anjou M (2009) Production of monoclonal antibodies by glycoengineered Pichia pastoris. J Biotechnol 139:318-325
32. Schulz BL, Stirnimann CU, Grimshaw JPA, Brozzo MS, Fritsch F, Mohorko E, Capitani G, Glockshuber R, Grütter MG, Aebi M (2009) Oxidoreductase activity of oligosaccharyltransferase subunits Ost3p and Ost6p defines site-specific glycosylation efficiency. Proc Natl Acad Sci USA 106:11061-11066
33. Sethuraman N, Choi BK, Prinz B, Meehl M, Stadheim TA (2011) Methods for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in Pichia pastoris. Patent application number US2011/025879
34. Sinclair AM, Elliott S (2005) Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J Pharm Sci 94:1626-1635
35. Swayne TC, Boldogh IR, Pon LA (2009) Imaging of the cytoskeleton and mitochondria in fixed budding yeast cells. Method Mol Biol 586:171-184
36. Ward M, Lin C, Victoria DC, Fox BP, Fox JA, Wong DL, Meerman HJ, Pucci JP, Fong RB, Heng MH, Tsurushita N, Gieswein C, Park M, Wang H (2004) Characterization of humanized antibodies secreted by Aspergillus niger. Appl Environ Microbiol 70:2567-2576
37. Waterham HR, Digan ME, Koutz PJ, Lair SV, Cregg JM (1997) Isolation of the Pichia pastoris glyceraldehyde-3-phosphate dehydrogenase gene and regulation and use of its promoter. Gene 186:37-44
38. Yan A, Lennarz WJ (2002) Studies on the function of oligosaccharyl transferase subunits. Stt3p is directly involved in the glycosylation process. J Biol Chem 277:47692-47700
39. Yan A, Lennarz WJ (2005) Two oligosaccharyl transferase complexes exist in yeast and associate with two different translocons. Glycobiology 15:1407-1415
40. Zhang N, Liu L, Dumitru CD, Houston-Cummings NR, Cukan M, Jiang Y, Li Y, Li F, Mitchell T, Mallem MR, Ou Y, Patel RN, Vo K, Wang H, Burnina I, Choi BK, Huber H, Stadheim TA, Zha D (2011) Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study. Mabs 3:289-298